Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06282406 · ClinicalTrials.gov registry record · NA

Pupil-Indexed Noninvasive Neuromodulation

A NA study of Paresis, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT06282406 is a NA study of Paresis that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06282406, a NA study of Paresis, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

Vagus nerve stimulation (VNS) is thought to activate neural pathways that release chemicals which promote plasticity and learning. Previous work has shown that the auricular branch of the vagus nerve innervates landmarks on the external ear. Work from the PI's laboratory has shown that electrical current applied to the external ear modulates physiological indexes of brain states implicated in the therapeutic effects of VNS. The broad objective of this project is to better understand physiological mechanisms modulated by auricular stimulation to support possible therapeutic effects in the form of motor learning.

Conditions Studied

Interventions

  • OTHER Sham
  • OTHER Transcutaneous Electrical Stimulation

Study Locations (1)

Pennsylvania

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2024-06-03
Est. Completion 2028-08-05
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT06282406

The ClinicalTrials.gov registry entry for NCT06282406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Paresis appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT06282406 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06282406 about?

NCT06282406 is a clinical study titled "Pupil-Indexed Noninvasive Neuromodulation". Vagus nerve stimulation (VNS) is thought to activate neural pathways that release chemicals which promote plasticity and learning. Previous work has shown that the auricular branch of the vagus nerve innervates landmarks on the external ear. Work from the PI's laboratory has shown that electrical cu...

What is the current status of trial NCT06282406?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2024-06-03. Estimated completion is 2028-08-05.

What conditions does trial NCT06282406 study?

This clinical trial studies the following conditions: Paresis.

What interventions are being tested in trial NCT06282406?

The interventions under investigation include: Sham (OTHER), Transcutaneous Electrical Stimulation (OTHER).

Who is sponsoring clinical trial NCT06282406?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06282406 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Paresis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.